Asia Pacific Biosimilars Business and Investment Opportunities Databook - Q2 2023 Update

According to the publisher, Asia Pacific biosimilar market size is expected to record a CAGR of 20.1% during 2023-2027 to reach US$12.397 billion by 2027, increasing from US$4.840 billion in 2023. Over the last five years, the sector has recorded a CAGR of 24.6% to reach US$3.884 billion in 2022.

This offering is a bundled offering, combining 5 countries and a key report covering Asia Pacific region. This report provides an in-depth data-centric analysis of the emerging opportunities in the biosimilar industry. It covers a detailed view of market size and forecast across various segments such as by product, type of cell, imaging technique, procedure, source of manufacturing, applications, type of technology, and end users.

This title is a bundled offering, combining the following 6 reports, covering 174+ tables and 246+ figures:

• Country Report 1 - Asia Pacific Biosimilars Business and Investment Opportunities Databook - Q2 2023 Update
• Country Report 2 - China Biosimilars Business and Investment Opportunities Databook - Q2 2023 Update
• Country Report 3 -Japan Biosimilars Business and Investment Opportunities Databook - Q2 2023 Update
• Country Report 4 -Australia Biosimilars Business and Investment Opportunities Databook - Q2 2023 Update
• Country Report 5 - India Biosimilars Business and Investment Opportunities Databook - Q2 2023 Update
• Country Report 6 - South Korea Biosimilars Business and Investment Opportunities Databook - Q2 2023 Update

Scope

This report provides an in-depth, data-centric analysis of the Asia Pacific biosimilar market 2018-2027. Below is a summary of key market segments:

Biosimilar Market Size By Product

• Monoclonal Antibody Biosimilars
• Insulin Biosimilar
• Biosimilar Interferons
• Other Biosimilar

Biosimilar Market Size By Type of Cell

• Mammalian
• Non-Mammalian

Biosimilar Market Size By Imaging Technique

• Magnetic Resonance Imaging Scanners
• Computed Tomography Scanners
• Positron Emission Tomography Scanners
• Others

Biosimilar Market Size By Procedure

• Invasive
• Non-Invasive

Biosimilar Market Size By Source of Manufacturing

• In-House
• Contract Manufacturing

Biosimilar Market Size By Applications

• Oncology
• Blood Disorders
• Growth Hormonal Deficiency
• Chronic & Autoimmune Disorders
• Infectious Diseases
• Others

Biosimilar Market Size By Type of Technology

• Mass Spectroscopy
• Chromatography
• Recombinant DNA technology
• Electrophoresis
• Others

Biosimilar Market Size By End User

• Hospital & Clinics
• Diagnostic Centres
• Others

Reasons to buy

• In-depth understanding of biosimilars market dynamics: Understand market opportunity, industry dynamics, key trends and drivers across different market segments and sub-segments of the industry in Asia Pacific.
• Develop market-specific strategies: Identify growth segments and target specific opportunities to formulate your investment strategy; assess market-specific key trends, drivers, and risks in the industry.
• Get market share analysis by end users: Get a detailed analysis across different end users such as hospitals & clinics, diagnostic centres within the Asia Pacific.